Friday, June 11, 2021 7:14:23 PM
Everything you are saying and the contents of this video are true in my opinion.
The government and FDA/NIH pushing the vaccination program despite its risks including:
lack of biological testing,
persistence of the spike protein in the blood/body,
concentration of the lipid substances (and possibly other vaccine substances) in lymph, bone marrow and ovaries,
inadequate, underreported and biased accounting for adverse effects and use of the VAERS,
inadequate followup to the vaccines,
bias and censorship in the media to quash the reporting of alternative views on the efficacy and prudence of the vaccine campaign,
and the dismissal of use of already approved drugs such as vitamin D3, zinc, hydroxychloroquin, ivermectin and fluvoxamine as preventatives and in the early stage of the disease.
There doesn't seem to be any accounting for the short and long term effects of the vaccines and the evolution of escape mutants and antibody dependent enhancement of the virus. I should say that I am not an anti-vaxer. I have gotten both shots of the Pfizer vaccine. I work as an ER doc and I have risk factors. I was in the Peace Corps where I got vaccinated for everything under the sun. I have probably had more than 200 vaccinations in my life.
The discussions in the video also reveal the group-thinking and inherent biases in the regulatory agencies that CytoDyn is up against. This all leads me to believe that approval in the US will be difficult until we have at least a statistically significant trial in another country or until some changes in the FDA occur. The approval of the Biogen Alzheimer drug on such scanty evidence of reducing amyloid plaque without clinical improvement has stirred up further controversy about FDA policies and practices. Perhaps this will bring closer scrutiny of FDA policies and result in some change.
As many have noted on this board, if CytoDyn were treated in the same as Gilead or Biogen we would have an EUA.
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM